Nicholas W. Van Hise

Efficacy of Oral Vancomycin in Preventing Recurrent<i>Clostridium difficile</i>Infection in Patients Treated With Systemic Antimicrobial Agents: Table 1.

Nicholas W. Van Hise, Alex Bryant, Erin Hennessey et al. · Clinical Infectious Diseases · 2016 · 90 citations · Full text

Antibacterial Agents, Antimicrobial Chemotherapy, Oral Vancomycin +18

Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study

Nicholas W. Van Hise, Vishnu Chundi, Vishal Didwania et al. · Drugs - Real World Outcomes · 2020 · 41 citations · Full text

PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent <i>Clostridioides difficile</i> Infection

Paul Feuerstadt, Teena Chopra, W Knapple et al. · Clinical Infectious Diseases · 2024 · 24 citations · Full text

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · Clinical and Translational Science · 2020 · 22 citations · Full text

Il-6 Receptor Antagonist, Acute Care, Immunology +13

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · 2020 · 19 citations · Full text

Immunology, Early Dosing, Antiviral Drug +17